303 related articles for article (PubMed ID: 36369093)
41. Differential effects of hyperhomocysteinemia on the lipid profiles and lipid ratios between patients with and without coronary artery disease: A retrospective observational study.
Wu DF; Liao QC; Lu F; Wang Z; Yu K; Deng JL
Medicine (Baltimore); 2022 Dec; 101(52):e32464. PubMed ID: 36595992
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
[TBL] [Abstract][Full Text] [Related]
43. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).
Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776
[TBL] [Abstract][Full Text] [Related]
44. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
[TBL] [Abstract][Full Text] [Related]
45. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.
Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W
J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076
[TBL] [Abstract][Full Text] [Related]
46. Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: A cohort study.
Ding M; Wennberg A; Gigante B; Walldius G; Hammar N; Modig K
PLoS Med; 2022 Aug; 19(8):e1004044. PubMed ID: 35951514
[TBL] [Abstract][Full Text] [Related]
47. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
[TBL] [Abstract][Full Text] [Related]
48. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
[TBL] [Abstract][Full Text] [Related]
49. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
[TBL] [Abstract][Full Text] [Related]
50. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
[TBL] [Abstract][Full Text] [Related]
51. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
[TBL] [Abstract][Full Text] [Related]
52. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
[TBL] [Abstract][Full Text] [Related]
53. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
Pan L; Lu G; Chen Z
Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
[TBL] [Abstract][Full Text] [Related]
54. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ
Dis Markers; 2015; 2015():591454. PubMed ID: 25852220
[TBL] [Abstract][Full Text] [Related]
55. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
56. Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance.
Martin SS; Qasim AN; Wolfe M; St Clair C; Schwartz S; Iqbal N; Schutta M; Bagheri R; Mehta NN; Rader DJ; Reilly MP
Am J Cardiol; 2011 Feb; 107(3):393-8. PubMed ID: 21257004
[TBL] [Abstract][Full Text] [Related]
57. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
[TBL] [Abstract][Full Text] [Related]
58. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
[TBL] [Abstract][Full Text] [Related]
59. Both serum apolipoprotein B and the apolipoprotein B/apolipoprotein A-I ratio are associated with carotid intima-media thickness.
Huang F; Yang Z; Xu B; Bi Y; Xu M; Xu Y; Lu J; Liu Y; Dai M; Zhou W; Wang W; Chen Y
PLoS One; 2013; 8(1):e54628. PubMed ID: 23359805
[TBL] [Abstract][Full Text] [Related]
60. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.
Talmud PJ; Hawe E; Miller GJ; Humphries SE
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1918-23. PubMed ID: 12426225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
